DaVita Inkomsten in het verleden
Verleden criteriumcontroles 4/6
De winst van DaVita is gedaald met een gemiddeld jaarlijks percentage van -2.4%, terwijl de winst van de Healthcare -industrie jaarlijks groeide met 5.4%. De inkomsten zijn groeide met een gemiddeld percentage van 1.7% per jaar. Het rendement op het eigen vermogen DaVita bedraagt 51% en de nettomarge bedraagt 6.5%.
Belangrijke informatie
-2.4%
Groei van de winst
8.3%
Groei van de winst per aandeel
Healthcare Groei van de industrie | 8.5% |
Inkomstengroei | 1.7% |
Rendement op eigen vermogen | 51.0% |
Nettomarge | 6.5% |
Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Is DaVita (NYSE:DVA) A Risky Investment?
Oct 29An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued
Sep 16DaVita Inc.'s (NYSE:DVA) Shares Lagging The Market But So Is The Business
Sep 01DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet
Jul 02Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?
Jun 19Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?
Jun 04Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes
May 22DaVita Stock Is A Hold As It Expands In Latin America
Mar 18Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost
Mar 13Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?
Mar 04DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 16Is DaVita (NYSE:DVA) Using Too Much Debt?
Feb 08DaVita: Assessing After The Rally
Dec 29DaVita Inc.'s (NYSE:DVA) Subdued P/E Might Signal An Opportunity
Dec 24DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet
Nov 08DaVita: Simple And Compelling After Sell-Off
Oct 26Returns On Capital Signal Difficult Times Ahead For DaVita (NYSE:DVA)
Oct 25DaVita: Continued Economic Hurdles, Market Expectations May Be Correct
Oct 05Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?
Aug 14DaVita (NYSE:DVA) Takes On Some Risk With Its Use Of Debt
Jul 31DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold
Jul 21Returns At DaVita (NYSE:DVA) Appear To Be Weighed Down
Jul 18DaVita Inc. (NYSE:DVA) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jul 03What Is DaVita Inc.'s (NYSE:DVA) Share Price Doing?
May 01These 4 Measures Indicate That DaVita (NYSE:DVA) Is Using Debt Extensively
Apr 17Investors Met With Slowing Returns on Capital At DaVita (NYSE:DVA)
Apr 03Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 40%?
Mar 08DaVita HealthCare Partners Q4 2022 Earnings Preview
Feb 21Moon Capital - DaVita: A Recession-Resistant Cash Generating Machine
Feb 08Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?
Jan 24Is DaVita (NYSE:DVA) A Risky Investment?
Jan 09DaVita: Shares Still Appear Cheap After Outlook Cut, Technicals Suggest Caution
Dec 12DaVita Q3 2022 Earnings Preview
Oct 27Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?
Oct 18Opbrengsten en kosten
Hoe DaVita geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 24 | 12,667 | 828 | 1,497 | 0 |
30 Jun 24 | 12,524 | 860 | 1,493 | 0 |
31 Mar 24 | 12,338 | 816 | 1,505 | 0 |
31 Dec 23 | 12,140 | 692 | 1,474 | 0 |
30 Sep 23 | 11,911 | 596 | 1,452 | 0 |
30 Jun 23 | 11,739 | 454 | 1,441 | 0 |
31 Mar 23 | 11,665 | 500 | 1,392 | 0 |
31 Dec 22 | 11,610 | 547 | 1,355 | 0 |
30 Sep 22 | 11,637 | 680 | 1,298 | 0 |
30 Jun 22 | 11,627 | 834 | 1,226 | 0 |
31 Mar 22 | 11,616 | 903 | 1,209 | 0 |
31 Dec 21 | 11,619 | 978 | 1,195 | 0 |
30 Sep 21 | 11,580 | 984 | 1,177 | 0 |
30 Jun 21 | 11,566 | 883 | 1,247 | 0 |
31 Mar 21 | 11,529 | 791 | 1,230 | 0 |
31 Dec 20 | 11,551 | 783 | 1,248 | 0 |
30 Sep 20 | 11,544 | 832 | 1,186 | 0 |
30 Jun 20 | 11,524 | 824 | 1,122 | 0 |
31 Mar 20 | 11,487 | 816 | 1,116 | 0 |
31 Dec 19 | 11,388 | 705 | 1,103 | 0 |
30 Sep 19 | 11,311 | 623 | 1,093 | 0 |
30 Jun 19 | 11,253 | 548 | 1,131 | 0 |
31 Mar 19 | 11,300 | 551 | 1,120 | 0 |
31 Dec 18 | 11,412 | 616 | 1,135 | 0 |
30 Sep 18 | 11,378 | 617 | 1,120 | 0 |
30 Jun 18 | 11,299 | 698 | 1,057 | 0 |
31 Mar 18 | 11,110 | 652 | 1,056 | 0 |
31 Dec 17 | 10,884 | 909 | 1,052 | 0 |
30 Sep 17 | 7,773 | 1,065 | 707 | 0 |
30 Jun 17 | 8,732 | 1,480 | 825 | 0 |
31 Mar 17 | 9,747 | 1,382 | 949 | 0 |
31 Dec 16 | 10,696 | 1,038 | 1,057 | 0 |
30 Sep 16 | 14,550 | 716 | 1,573 | 0 |
30 Jun 16 | 14,347 | 361 | 1,536 | 0 |
31 Mar 16 | 14,065 | 478 | 1,497 | 0 |
31 Dec 15 | 9,973 | 323 | 1,031 | 0 |
30 Sep 15 | 13,565 | 484 | 1,399 | 0 |
30 Jun 15 | 13,290 | 452 | 1,369 | 0 |
31 Mar 15 | 13,027 | 429 | 1,319 | 0 |
31 Dec 14 | 12,781 | 723 | 1,262 | 0 |
30 Sep 14 | 12,519 | 727 | 1,224 | 0 |
30 Jun 14 | 12,270 | 680 | 1,207 | 0 |
31 Mar 14 | 11,971 | 787 | 1,176 | 0 |
31 Dec 13 | 11,759 | 620 | 1,176 | 0 |
Kwaliteitswinsten: DVA heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (6.5%) DVA } zijn hoger dan vorig jaar (5%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van DVA is de afgelopen 5 jaar met 2.4% per jaar gedaald.
Versnelling van de groei: De winstgroei van DVA over het afgelopen jaar ( 39% ) overtreft het 5-jarig gemiddelde ( -2.4% per jaar).
Winst versus industrie: De winstgroei DVA over het afgelopen jaar ( 39% ) overtrof de Healthcare -sector 11.4%.
Rendement op eigen vermogen
Hoge ROE: Hoewel het rendement op eigen vermogen ( 51% ) van DVA uitstekend is, is deze metriek vertekend vanwege hun hoge schuldenniveau.